Neng Jiang

1.2k total citations
33 papers, 1.0k citations indexed

About

Neng Jiang is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Neng Jiang has authored 33 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pharmacology, 12 papers in Endocrinology, Diabetes and Metabolism and 12 papers in Physiology. Recurrent topics in Neng Jiang's work include Cholinesterase and Neurodegenerative Diseases (16 papers), Diabetes Treatment and Management (11 papers) and Alzheimer's disease research and treatments (10 papers). Neng Jiang is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (16 papers), Diabetes Treatment and Management (11 papers) and Alzheimer's disease research and treatments (10 papers). Neng Jiang collaborates with scholars based in China. Neng Jiang's co-authors include Sai‐Sai Xie, Xiaobing Wang, Ling‐Yi Kong, Jinshuai Lan, Kelvin D.G. Wang, Zhongrui Li, Suyi Li, Jing Liu, Ming Huang and Wenying Yu and has published in prestigious journals such as Journal of Medicinal Chemistry, British Journal of Pharmacology and Tetrahedron.

In The Last Decade

Neng Jiang

32 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Neng Jiang China	16	697	419	397	257	250	33	1.0k
Xingshu Li China	23	948 1.4×	607 1.4×	503 1.3×	445 1.7×	309 1.2×	29	1.5k
Zhenghuai Tan China	26	1.1k 1.6×	527 1.3×	679 1.7×	382 1.5×	562 2.2×	57	1.7k
Lorna Piazzi Italy	18	987 1.4×	769 1.8×	658 1.7×	373 1.5×	257 1.0×	25	1.5k
Tarek Mohamed Canada	20	488 0.7×	314 0.7×	335 0.8×	266 1.0×	377 1.5×	25	995
Ignacio Moraleda Spain	24	922 1.3×	655 1.6×	614 1.5×	440 1.7×	257 1.0×	36	1.4k
Zhipei Sang China	23	640 0.9×	353 0.8×	363 0.9×	507 2.0×	259 1.0×	80	1.4k
Pavan Srivastava India	13	545 0.8×	315 0.8×	376 0.9×	319 1.2×	292 1.2×	15	1.1k
Xiaoming Qiang China	20	757 1.1×	414 1.0×	454 1.1×	174 0.7×	359 1.4×	25	1.0k
Lhassane Ismaïli France	22	754 1.1×	752 1.8×	510 1.3×	318 1.2×	198 0.8×	76	1.4k
Katarína Špilovská Czechia	14	553 0.8×	346 0.8×	365 0.9×	194 0.8×	139 0.6×	15	819

Countries citing papers authored by Neng Jiang

Since Specialization

Citations

This map shows the geographic impact of Neng Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neng Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neng Jiang more than expected).

Fields of papers citing papers by Neng Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neng Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neng Jiang. The network helps show where Neng Jiang may publish in the future.

Co-authorship network of co-authors of Neng Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Neng Jiang. A scholar is included among the top collaborators of Neng Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neng Jiang. Neng Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wei, Changhong, et al.. (2025). Dual Modulator of FXR and HSD17B13: Revitalizing FXR Therapies in MASH. Journal of Medicinal Chemistry. 68(6). 6104–6107. 1 indexed citations

Liu, Jing, Han Wu, Chunli Tang, et al.. (2025). Rational design of dual-agonist peptides targeting GLP-1 and NPY2 receptors for regulating glucose homeostasis and body weight with minimal nausea and emesis. European Journal of Medicinal Chemistry. 287. 117320–117320. 1 indexed citations

Wang, Shuang, Chunli Tang, Jing Lin, et al.. (2025). Strategic Design of Triple GLP-1R/GCGR/GIPR Agonists with Varied Receptor Potency: Achieving Comparable Glycemic and Weight Reduction Effects. Journal of Medicinal Chemistry. 68(19). 20765–20788.

Huang, S.C., Guohui Zhong, Chunli Tang, et al.. (2024). In vitro and in vivo Biological Evaluation of Newly Tacrine-Selegiline Hybrids as Multi-Target Inhibitors of Cholinesterases and Monoamine Oxidases for Alzheimer’s Disease. Drug Design Development and Therapy. Volume 18. 133–159. 5 indexed citations

Zeng, Huihui, Zixuan Wang, Junde Li, et al.. (2024). Three types of enzymes complete the furanocoumarins core skeleton biosynthesis in Angelica sinensis. Phytochemistry. 222. 114102–114102. 5 indexed citations

Zhong, Guohui, et al.. (2023). Design, synthesis, and biological evaluation of novel capsaicin-tacrine hybrids as multi-target agents for the treatment of Alzheimer's disease. Bioorganic Chemistry. 143. 107026–107026. 17 indexed citations

Yang, Qimeng, Feng Zhou, Jialing Wang, et al.. (2022). Peptide-based long-acting co-agonists of GLP-1 and cholecystokinin 1 receptors as novel anti-diabesity agents. European Journal of Medicinal Chemistry. 233. 114214–114214. 9 indexed citations

Zhong, Guohui, Jie Guo, Di Su, et al.. (2022). Novel AP2238-clorgiline hybrids as multi-target agents for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation. Bioorganic Chemistry. 130. 106224–106224. 13 indexed citations

Yuan, Yongliang, et al.. (2022). Discovery of a potent and long-acting Xenopus GLP-1-based GLP-1/glucagon/Y2 receptor triple agonist. European Journal of Medicinal Chemistry. 247. 115036–115036. 6 indexed citations

10.

Li, Qing, et al.. (2021). Identification and structure–activity relationship exploration of uracil-based benzoic acid and ester derivatives as novel dipeptidyl Peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus. European Journal of Medicinal Chemistry. 225. 113765–113765. 12 indexed citations

11.

Xie, Sai‐Sai, Jing Liu, Chunli Tang, et al.. (2020). Design, synthesis and biological evaluation of rasagiline-clorgyline hybrids as novel dual inhibitors of monoamine oxidase-B and amyloid-β aggregation against Alzheimer’s disease. European Journal of Medicinal Chemistry. 202. 112475–112475. 23 indexed citations

12.

Jiang, Neng, Qing Li, Qimeng Yang, et al.. (2020). Design of novel Xenopus GLP-1-based dual glucagon-like peptide 1 (GLP-1)/glucagon receptor agonists. European Journal of Medicinal Chemistry. 212. 113118–113118. 15 indexed citations

13.

Jiang, Neng, Jing Liu, Xiaona Sun, et al.. (2019). Novel chromanone-dithiocarbamate hybrids as multifunctional AChE inhibitors with β-amyloid anti-aggregation properties for the treatment of Alzheimer’s disease. Bioorganic Chemistry. 89. 103027–103027. 38 indexed citations

14.

Liu, Jing, Jinshuai Lan, Yongbing Sun, et al.. (2018). Coumarin-dithiocarbamate hybrids as novel multitarget AChE and MAO-B inhibitors against Alzheimer’s disease: Design, synthesis and biological evaluation. Bioorganic Chemistry. 81. 512–528. 88 indexed citations

15.

Jiang, Neng, Qichun Huang, Jing Liu, et al.. (2018). Design, synthesis and biological evaluation of new coumarin-dithiocarbamate hybrids as multifunctional agents for the treatment of Alzheimer's disease. European Journal of Medicinal Chemistry. 146. 287–298. 91 indexed citations

16.

Xie, Sai‐Sai, Jinshuai Lan, Xiaobing Wang, et al.. (2015). Multifunctional tacrine–trolox hybrids for the treatment of Alzheimer's disease with cholinergic, antioxidant, neuroprotective and hepatoprotective properties. European Journal of Medicinal Chemistry. 93. 42–50. 69 indexed citations

17.

Xie, Sai‐Sai, Xiaobing Wang, Neng Jiang, et al.. (2015). Multi-target tacrine-coumarin hybrids: Cholinesterase and monoamine oxidase B inhibition properties against Alzheimer's disease. European Journal of Medicinal Chemistry. 95. 153–165. 140 indexed citations

18.

Jiang, Neng, Suyi Li, Sai‐Sai Xie, et al.. (2014). Design, synthesis and evaluation of multifunctional salphen derivatives for the treatment of Alzheimer's disease. European Journal of Medicinal Chemistry. 87. 540–551. 35 indexed citations

19.

Huang, Ming, Sai‐Sai Xie, Neng Jiang, et al.. (2014). Multifunctional coumarin derivatives: Monoamine oxidase B (MAO-B) inhibition, anti-β-amyloid (Aβ) aggregation and metal chelation properties against Alzheimer’s disease. Bioorganic & Medicinal Chemistry Letters. 25(3). 508–513. 66 indexed citations

20.

Li, Suyi, et al.. (2013). Design, synthesis and evaluation of novel tacrine–rhein hybrids as multifunctional agents for the treatment of Alzheimer's disease. Organic & Biomolecular Chemistry. 12(5). 801–814. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact